Blood clot
AstraZeneca Plc
Blood clot
Business Day
Global
Guardian
Health
Latest
Oxford
Premium Times
Uncategorized
Oxford Pauses Covid-19 Vaccine Study in Kids, Awaits More Data on Blood Clot Issues
The University of Oxford said on Tuesday it had paused a small UK trial testing the COVID-19 vaccine it developed with AstraZeneca Plc in children and teenagers, as it waits
AstraZeneca vaccine
Blood clot
Business Day
Global
Guardian
Health
Premium Times
Uncategorized
UK Regulator Found 30 Cases of Blood Clot Events after AstraZeneca Vaccine Use
British regulators on Thursday said they have identified 30 cases of rare blood clot events after the use of the AstraZeneca COVID-19 vaccine, 25 more than the agency previously reported.
AstraZeneca vaccine
Blood clot
Business Day
Concerns
Global
Guardian
Health
Premium Times
Uncategorized
Canada Pauses AstraZeneca Vaccine for People Under 55 Over Blood Clot Concerns
Canada has suspended the use of the Oxford-AstraZeneca coronavirus vaccine for people under age 55 following concerns it might be linked to rare blood clots. The National Advisory Committee on
